Literature DB >> 10803934

Expression of functional granulocyte colony-stimulating factor receptors on human B-lymphocytic leukemia cells.

A Handa1, T Kashimura, S Takeuchi, A Yamamoto, I Murohashi, M Bessho, K Hirashima.   

Abstract

We analyzed the expression of cell surface antigens and granulocyte colony-stimulating factor (G-CSF) receptors using flow cytometry, the expression of G-CSF mRNA receptor, using reverse transcription (RT)-PCR, and tested the effect of G-CSF on leukemia colony formation. A total of 14 lymphocytic leukemia patients were examined, seven with acute lymphocytic leukemia (ALL), two with adult T-cell leukemia (ATL), two with B-chronic lymphocytic leukemia (CLL), two with chronic myelocytic leukemia in lymphoid blastic crisis (CML-LBC), and one with plasma cell leukemia (PCL). The presence of G-CSF receptors was demonstrated in 4/14 (29%) patients, two with ALL, one with CLL, and one with CML-LBC, and was associated with stimulation of leukemia clonogenic cell growth by G-CSF. In addition, all four positive leukemia cell types expressed typical B-cell antigens. Our results indicated that G-CSF receptors are expressed on some portion of B-lymphoid leukemia and that their receptors are functional as growth stimulators.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803934     DOI: 10.1007/s002770050567

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  2 in total

1.  Granulocyte colony stimulating factor increases drug resistance of leukaemic blast cells to daunorubicin.

Authors:  László Márkász; György Hajas; Andrea Kiss; Beáta Lontay; Eva Rajnavölgyi; Ferenc Erdodi; Eva Oláh
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

2.  Pro-inflammatory-Related Loss of CXCL12 Niche Promotes Acute Lymphoblastic Leukemic Progression at the Expense of Normal Lymphopoiesis.

Authors:  Juan Carlos Balandrán; Jessica Purizaca; Jennifer Enciso; David Dozal; Antonio Sandoval; Elva Jiménez-Hernández; Leticia Alemán-Lazarini; Vadim Perez-Koldenkova; Henry Quintela-Núñez Del Prado; Jussara Rios de Los Ríos; Héctor Mayani; Vianney Ortiz-Navarrete; Monica L Guzman; Rosana Pelayo
Journal:  Front Immunol       Date:  2017-01-05       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.